Credit Suisse’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$708K Buy
142,730
+3,537
+3% +$22.6K ﹤0.01% 2468
2023
Q4
$1.2M Buy
139,193
+18,394
+15% +$135K ﹤0.01% 2224
2023
Q3
$838K Sell
120,799
-5,732
-5% -$34.6K ﹤0.01% 2390
2023
Q2
$728K Buy
126,531
+55,232
+77% +$357K ﹤0.01% 2590
2023
Q1
$453K Buy
71,299
+21
+0% +$200 ﹤0.01% 2803
2022
Q4
$838K Sell
71,278
-1,077
-1% -$13.1K ﹤0.01% 2462
2022
Q3
$857K Buy
72,355
+14,191
+24% +$207K ﹤0.01% 2436
2022
Q2
$663K Buy
58,164
+33,020
+131% +$348K ﹤0.01% 2661
2022
Q1
$282K Buy
25,144
+1,880
+8% +$16.9K ﹤0.01% 3247
2021
Q4
$327K Buy
+23,264
New +$407K ﹤0.01% 4085

Other funds holding ALHC

Credit Suisse's ALHC Position: Q1 2024 in Review

Credit Suisse increased its Alignment Healthcare (ALHC) stake by 2.5% in Q1 2024, buying an estimated $22.6K and bringing the position to 142,730 shares worth $708K. The position accounts for ﹤0.01% of the portfolio, ranked #2468.

Credit Suisse first reported a position in ALHC in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.2M in Q4 2023. 130 funds tracked by Wall St. Rank hold ALHC as of Q1 2024.

  • Credit Suisse held 142,730 shares of Alignment Healthcare worth $708K as of Q1 2024.
  • Credit Suisse bought 3,537 Alignment Healthcare shares in Q1 2024, an estimated $22.6K.
  • Alignment Healthcare made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2468 holding.
  • Credit Suisse first reported a position in Alignment Healthcare in Q4 2021 and has held it in 10 quarters since.
  • Credit Suisse's Alignment Healthcare position peaked at $1.2M in Q4 2023.
  • 130 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.